Literature DB >> 24042197

Long-term analyses of innervation and neuromuscular integrity in the Trembler-J mouse model of Charcot-Marie-Tooth disease.

Jessica Renee Nicks1, Sooyeon Lee, Kathryne Ann Kostamo, Andrew Benford Harris, Amanda M Sookdeo, Lucia Notterpek.   

Abstract

A large fraction of hereditary demyelinating neuropathies, classified as Charcot-Marie-Tooth disease type 1A, is associated with misexpression of peripheral myelin protein 22. In this study, we characterized morphologic and biochemical changes that occur with diseaseprogression in neuromuscular tissue of Trembler-J mice, a spontaneous rodent model of Charcot-Marie-Tooth disease type 1A. Using age-matched, 2- and 10-month-old, wild-type and Trembler-J mice, we observed neuromuscular deficits that progress from distal to proximal regions. The impairments in motor performance are underlined by degenerative events at distal nerve segments and structural alterations at nerve-muscle synapses. Furthermore, skeletal muscle of affected mice showed reduced myofiber diameter, increased expression of the muscle atrophy marker muscle ring-finger protein 1, and fiber type switching. A dietary intervention of intermittent fasting attenuated these progressive changes and supported distal nerve myelination and neuromuscular junction integrity. In addition to the well-characterized demyelination aspects of this model, our investigations identified distinct degenerative events in distal nerves and muscle of affected neuropathic mice. Therefore, therapeutic studies aimed at slowing or reversing the neuropathic features of these disorders should include the examination of muscle tissue, as well as neuromuscular contact sites.

Entities:  

Mesh:

Year:  2013        PMID: 24042197      PMCID: PMC3810994          DOI: 10.1097/NEN.0b013e3182a5f96e

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  54 in total

1.  Neurons promote the translocation of peripheral myelin protein 22 into myelin.

Authors:  S Pareek; L Notterpek; G J Snipes; R Naef; W Sossin; J Laliberté; S Iacampo; U Suter; E M Shooter; R A Murphy
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

2.  Genetic and clinical aspects of Charcot-Marie-Tooth's disease.

Authors:  H Skre
Journal:  Clin Genet       Date:  1974       Impact factor: 4.438

3.  Development of early postnatal peripheral nerve abnormalities in Trembler-J and PMP22 transgenic mice.

Authors:  A M Robertson; C Huxley; R H King; P K Thomas
Journal:  J Anat       Date:  1999-10       Impact factor: 2.610

4.  Matrix metalloproteinase mediated degradation of basement membrane proteins in Trembler J neuropathy nerves.

Authors:  A Misko; T Ferguson; L Notterpek
Journal:  J Neurochem       Date:  2002-11       Impact factor: 5.372

Review 5.  Progress in clinical neurosciences: Charcot-Marie-Tooth disease and related inherited peripheral neuropathies.

Authors:  T J Benstead; I A Grant
Journal:  Can J Neurol Sci       Date:  2001-08       Impact factor: 2.104

6.  Identification of ubiquitin ligases required for skeletal muscle atrophy.

Authors:  S C Bodine; E Latres; S Baumhueter; V K Lai; L Nunez; B A Clarke; W T Poueymirou; F J Panaro; E Na; K Dharmarajan; Z Q Pan; D M Valenzuela; T M DeChiara; T N Stitt; G D Yancopoulos; D J Glass
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

7.  Motor unit number estimate of distal and proximal muscles in Charcot-Marie-Tooth disease.

Authors:  Richard A Lewis; Jun Li; Darren R Fuerst; Michael E Shy; Karen Krajewski
Journal:  Muscle Nerve       Date:  2003-08       Impact factor: 3.217

8.  Nerve conduction abnormalities in the trembler-j mouse: a model for Charcot-Marie-Tooth disease type 1A?

Authors:  Gregg D Meekins; Michael J Emery; Michael D Weiss
Journal:  J Peripher Nerv Syst       Date:  2004-09       Impact factor: 3.494

9.  Emerging role for autophagy in the removal of aggresomes in Schwann cells.

Authors:  Jenny Fortun; William A Dunn; Shale Joy; Jie Li; Lucia Notterpek
Journal:  J Neurosci       Date:  2003-11-19       Impact factor: 6.167

10.  Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.

Authors:  Edith Passage; Jean Chrétien Norreel; Pauline Noack-Fraissignes; Véronique Sanguedolce; Josette Pizant; Xavier Thirion; Andrée Robaglia-Schlupp; Jean François Pellissier; Michel Fontés
Journal:  Nat Med       Date:  2004-03-21       Impact factor: 53.440

View more
  3 in total

1.  Structural and Functional Abnormalities of the Neuromuscular Junction in the Trembler-J Homozygote Mouse Model of Congenital Hypomyelinating Neuropathy.

Authors:  Alexandra N Scurry; Dante J Heredia; Cheng-Yuan Feng; Gregory B Gephart; Grant W Hennig; Thomas W Gould
Journal:  J Neuropathol Exp Neurol       Date:  2016-02-25       Impact factor: 3.685

2.  Rapamycin improves peripheral nerve myelination while it fails to benefit neuromuscular performance in neuropathic mice.

Authors:  Jessica Nicks; Sooyeon Lee; Andrew Harris; Darin J Falk; Adrian G Todd; Karla Arredondo; William A Dunn; Lucia Notterpek
Journal:  Neurobiol Dis       Date:  2014-07-09       Impact factor: 5.996

3.  Transient auditory nerve demyelination as a new mechanism for hidden hearing loss.

Authors:  Guoqiang Wan; Gabriel Corfas
Journal:  Nat Commun       Date:  2017-02-17       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.